onda

BOARD OF DIRECTORS

The Board of Directors (BoD) runs the general affairs and represents the VPH Institute in all circumstances. Its main duty is to drive the Institute policy, setting the agendas, proposing specific actions and approving the annual business plan.

The current Board of Directors is composed by the representatives of the supporting members, eleven prestigious organisations that excel worldwide for their research quality and their focus on in silico medicine.
  • Prof Liesbet Geris

    Executive Director

    Prof.Liesbet Geris

    Universities of Liège and KUL – Leuven (Belgium)

  • Rossana Alessandrello

    Director

    Rossana Alessandrello

    Agència de Qualitat i Avaluació Sanitàries de Catalunya - AQuAS (Spain)

  • Prof.Ilse Jonkers

    Director

    Prof.Ilse Jonkers

    KULeuven (Belgium)

  • Dr. Irene Vignon-Clementel

    Director

    Dr. Irene Vignon-Clementel

    Inria (France)

  • Prof. Reinhard Schneider

    Director

    Prof. Reinhard Schneider

    Luxembourg Centre for Systems Biomedicine (Luxembourg)

  • Prof.Leif Rune Hellevik

    Director

    Prof.Leif Rune Hellevik

    Norwegian University of Science and Technology (Norway)

  • Prof.Alfons Hoekstra

    Director

    Prof.Alfons Hoekstra

    University of Amsterdam (Netherlands)

  • Prof.Poul Nielsen

    Director

    Prof.Poul Nielsen

    University of Auckland (New Zealand)

  • Prof.Marco Viceconti

    Director

    Prof.Marco Viceconti

    University of Bologna (Italy)

  • Dr.Claudio Capelli

    Director

    Dr.Claudio Capelli

    UCL Institute of Cardiovascular Science / Great Ormond Street Hospital for Children (United Kingdom)

  • Dr.Andrew Narracott

    Director

    Dr.Andrew Narracott

    University of Sheffield (United Kingdom)

History of Directors >

News

More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

ARCHIVE

Read all the newsletters of the VPH Institute

GO